Stay updated with breaking news from Sofpulse Electroceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Endonovo Therapeutics (OTCMKTS:ENDV – Get Rating) and InMode (NASDAQ:INMD – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Analyst Ratings This is a summary of current recommendations and price […]
Endonovo Therapeutics (OTCMKTS:ENDV – Get Rating) and Nuwellis (NASDAQ:NUWE – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Analyst Ratings This is a breakdown of recent recommendations and […]
Endonovo Therapeutics (OTCMKTS:ENDV – Get Rating) and LivaNova (NASDAQ:LIVN – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership. Volatility and Risk Endonovo Therapeutics has a beta of 0.25, suggesting […]
Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 43,000 shares, a growth of 15.0% from the March 31st total of 37,400 shares. Based on an average daily volume of 529,000 shares, the days-to-cover ratio is […]
Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Rating) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.02 and traded as low as $0.01. Endonovo Therapeutics shares last traded at $0.01, with a volume of 237,265 shares trading hands. Endonovo Therapeutics Trading Down 13.0 % […]